CoChat

Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study

Terra, J. L., Montgomery, S. A. · 1998 · International Clinical Psychopharmacology

The DOI matches its Crossref record, with a small difference in title or year.

Abstract

This double-blind placebo-controlled study specifically tested the efficacy of fluvoxamine, at a dose of 100 mg a day, in reducing the risk of new episodes of depression. Out of 436 patients treated openly with fluvoxamine 283 patients fulfilled stringent criteria to define responders at 6 weeks. A total of 204 patients maintained their remission throughout a continuation treatment period of 18 weeks and then entered the prophylactic study. They were randomly assigned to receive either fluvoxamine 100 mg a day or placebo for 1 year. There were significantly fewer recurrences of new episodes of depression in the fluvoxamine group compared with the placebo group (p < 0.001). The significant advantage for fluvoxamine was also seen in the Kaplan-Meier analysis of time to recurrence (p < 0.001). The clear-cut efficacy of 100 mg of fluvoxamine and the good tolerabilitv and side-effect profile demonstrated in this study support the view that fluvoxamine is particularly suitable for maintenance or prophylactic treatment.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004850-199803000-00001

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 75

Metadata

Authors
Terra, J. L., & Montgomery, S. A.
Affiliations
  • Centre Hospitalier Le Vinatier (FR)
  • Imperial College London (GB)
Venue
International Clinical Psychopharmacology
Published
1998-03
Volume
13
Issue
2
Pages
55-62
ISSN
0268-1315 (ISSN-L)
OpenAlex
W4300431066
Cited by
51
References
0
Citations by year
2025: 3 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 2 · 2016: 1 · 2015: 3 · 2012: 2
FWCI
2.44
Type
journal article
Language
en
Open access
closed
Locations
International Clinical Psychopharmacology (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
fluvoxamine, depression recurrence, depression prevention, maintenance therapy, selective serotonin reuptake inhibitors, antidepressant efficacy, remission

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study. https://app.cochat.ai/papers/10.1097/00004850-199803000-00001
The paper
Terra, J. L., & Montgomery, S. A. (1998). Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199803000-00001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.